Evolent's earnings call reflects a strong performance in adjusted EBITDA and promising new partnerships, including a notable agreement with Aetna. Despite some challenges in revenue guidance and exchange business headwinds, the company's progress in AI and automation, along with a robust business pipeline, suggests a positive outlook.

Company Guidance

During the Evolent Earnings Conference Call for the second quarter of fiscal year 2025, several key metrics were highlighted regarding the company's performance and future outlook. Evolent reported a Q2 adjusted EBITDA of $37.5 million, surpassing expectations, and announced new revenue agreements anticipated to generate over $250 million by Q1 2026. The company expects to reach at least $2.5 billion in revenue by 2026, driven by a robust pipeline valued at over $1 billion. Evolent is leveraging AI to improve operational efficiency, with a target to auto-approve 80% of current authorization volumes within 24 months. The guidance for full-year adjusted EBITDA has been updated to a range of $140 million to $165 million. For Q3, the adjusted EBITDA is expected to be between $34 million and $42 million, with revenue projections of $460 million to $480 million. The call also discussed the company's strategic focus on organic growth, margin expansion, and capital allocation, including partnerships with major players like Aetna and the incorporation of AI-driven solutions to enhance member experience and reduce costs.

Strong Adjusted EBITDA Performance

Evolent reported Q2 adjusted EBITDA of $37.5 million, which was in the top half of their range, driven by strong results across both their Tech and Services and Performance Suite models.

New Partner Announcements and Business Pipeline

Evolent announced four new revenue agreements, bringing the total to 11 new agreements year-to-date. They expect these partnerships to generate over $250 million in new revenue by Q1 2026.

AI and Automation Advancements

Evolent has improved review efficiency by roughly 11% in the last quarter due to AI integration, and they aim to become an AI-first company, targeting 80% auto approval of current authorization volume.

Promising Partnership with Aetna

Evolent announced a partnership with Aetna for 250,000 Medicare Advantage members in Florida, with plans to expand to additional states over time.

Capital Allocation Strategy

Evolent plans to invest in organic product development and use free cash to deleverage, with no expected M&A in the near or medium term.

Evolent Health (EVH) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

EVH Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Oct 29, 2025	2025 (Q3)	0.11 / -	0.04	―	―	―
Aug 07, 2025	2025 (Q2)	0.07 / -0.10	0.3	-133.33% (-0.40)
May 08, 2025	2025 (Q1)	0.09 / 0.06	0.34	-82.35% (-0.28)
Feb 20, 2025	2024 (Q4)	0.03 / -0.02	0.23	-108.70% (-0.25)
Nov 07, 2024	2024 (Q3)	0.31 / 0.04	0.3	-86.67% (-0.26)
Aug 08, 2024	2024 (Q2)	0.24 / 0.30	0.14	114.29% (+0.16)
May 09, 2024	2024 (Q1)	0.24 / 0.34	0.21	61.90% (+0.13)
Feb 22, 2024	2023 (Q4)	0.17 / 0.23	0.1	130.00% (+0.13)
Nov 02, 2023	2023 (Q3)	0.10 / 0.30	0.59	-49.15% (-0.29)
Aug 02, 2023	2023 (Q2)	0.15 / 0.14	0.1	40.00% (+0.04)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

EVH Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Aug 07, 2025	$9.69	$9.00	-7.12%
May 08, 2025	$10.78	$9.05	-16.05%
Feb 20, 2025	$10.71	$10.43	-2.61%
Nov 07, 2024	$24.57	$13.36	-45.62%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Evolent Health (EVH) report earnings?

Evolent Health (EVH) is schdueled to report earning on Oct 29, 2025, After Close (Confirmed).

What is Evolent Health (EVH) earnings time?

Evolent Health (EVH) earnings time is at Oct 29, 2025, After Close (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is EVH EPS forecast?

EVH EPS forecast for the fiscal quarter 2025 (Q3) is 0.11.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing